Evaluation and Validation of New Biomarkers by Mass Spectrometry (DG7)

Université de Sherbrooke

Status: Completed

Conditions: Diabetes Mellitus

Study type: Observational

Funder types: Other

Identifiers

NCT01025973

09-110

Details and patient eligibility

About

The investigators will perform biochemical and metabolic evaluations on cord blood, venous blood of the mother and urine of the foetus and mother using time-of-flight and tandem mass spectrometry. The investigators could evaluate, dose and validate gestational diabetes mellitus biomarkers of the fetus and mother.

Enrollment: 99 patients

Sex: All

Ages: 1+ day old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

For women:

• Aged 18 or more
• 24 weeks of gestation or more
• Type 1, type 2 or gestational diabetes mellitus for group 1
• Without diabetes for group 2.

For newborn:

• 37 weeks of gestation or more
• Birth weight 2500 g or more

Exclusion criteria

• Multiple birth

Trial design

99 participants in 2 patient groups

Diabetes Mellitus

Description:

Patients with type 1, type 2 or gestational diabetes mellitus

Normal pregnancy

Description:

Patient without diabetes mellitus